Jeffrey R Immelt
CIK 1233164 · Chairman and CEO · last filed 2026-10-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
GE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
41 FARNSWORTH STREET
BOSTON, MA 02210
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BE | Director | 201,324 | $196.15 | $39.49M | -$5.37M | 30 | 2026-10-02 |
| TWLO | Director | 34,874 | $206.29 | $7.19M | $2.05M | 25 | 2026-09-17 |
| NeueHealth, Inc. (BHG) Delisted | Director | 0 | $16.35 | $0 | $1.25M | 6 | 2025-10-06 |
| NeueHealth, Inc. (NEUE) Delisted | Director | 23,919 | $6.75 | $161.5K | $0 | 2 | 2025-05-15 |
| Desktop Metal, Inc. (DM) Delisted | Director | 1,794 | $4.96 | $8.9K | $0 | 6 | 2024-06-10 |
| Desktop Metal, Inc. (DM.WS) Delisted | Director | 39,256 | $4.16 | $163.3K | $0 | 1 | 2020-12-11 |
| ATHENAHEALTH INC (ATHN) Delisted | Director | 18,762 | $9.59 | $179.9K | $2.00M | 11 | 2019-02-04 |
| GE | Chairman and CEO | 520,647 | $316.20 | $164.63M | $29.15M | 30 | 2017-05-15 |
Recent Filings · Page 8 of 12
114 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-08-07 | TWLO | Buy (P) | +8,500 | $1.04M | EDGAR |
| 2019-06-21 | TWLO | Grant (A) | +3,130 | $0 | EDGAR |
| 2019-02-13 | — | Disp (D) | −18,762 | -$2.53M | |
| 2019-02-04 | ATHENAHEALTH INC (ATHN) Delisted | Grant (A) | +1,113 | $0 | EDGAR |
| 2019-01-03 | ATHENAHEALTH INC (ATHN) Delisted | Grant (A) | +1,145 | $0 | EDGAR |
| 2018-12-04 | ATHENAHEALTH INC (ATHN) Delisted | Grant (A) | +1,131 | $0 | EDGAR |
| 2018-11-05 | ATHENAHEALTH INC (ATHN) Delisted | Grant (A) | +1,179 | $0 | EDGAR |
| 2018-10-03 | ATHENAHEALTH INC (ATHN) Delisted | Grant (A) | +1,185 | $0 | EDGAR |
| 2018-09-06 | ATHENAHEALTH INC (ATHN) Delisted | Grant (A) | +3,776 | $0 | EDGAR |
| 2018-06-08 | ATHENAHEALTH INC (ATHN) Delisted | Grant (A) | +1,931 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.